Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aion Therapeutic Inc C.AION

Alternate Symbol(s):  ANTCF

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Comment by nightowl21on May 05, 2022 11:28pm
163 Views
Post# 34661062

RE:Apollon Acquires Intellectual Property from Aion

RE:Apollon Acquires Intellectual Property from AionI hope a few other shareholders dig into the substance of this news release!

1. UK Apollon has approx 700 million shares outstanding.....and they are giving Aion
     Regular shareholders 4.0 million shares as partial payment to give up
       Our rights to these patents!

2. The Royalty as stated is 4.0% of  Net Revenue!....usually royalties are paid out
     based on a % of the sales of the product!  Who knows what gets thrown into the pot
     To to end up with a Net Revene number.....I think we should hear some more
      Supporting data...to reassure Aion Shareholders...presume this was negotiated
      by Graham Simmonds/Paul Crath!   Aion insiders own a lot of Aion shares
       so I am comfortable this should be good all around....ie for both Aion insiders
        And Aion regular shareholders like the rest of us that invested for the long term!
        Maybe we just need some supporting data! So we can understand what the
        payback to regular shareholders will actually look like...in return for giving
         up our rights to these patents! 

I would encourage Aion shareholders to do their own DD....I am invested in this
project primarily because of these Cancer Patents
<< Previous
Bullboard Posts
Next >>